{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:08Z","timestamp":1791987008149,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1136\/ard.2009.119321","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T12:50:19Z","timestamp":1253883019000},"page":"598-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Mirko","family":"Manetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ibba-Manneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Franca","family":"Milia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Benelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Letizia","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.119321_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"10.1136\/ard.2009.119321_bib2","first-page":"iii3","article-title":"Overview of pathogenesis of systemic sclerosis","volume":"48","author":"Abraham","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.119321_bib3","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.119321_bib4","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1002\/art.22940","article-title":"Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients","volume":"56","author":"Manetti","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.119321_bib5","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/art.23806","article-title":"Endothelial\/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis","volume":"58","author":"Manetti","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.119321_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2009.119321_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.1990.tb05340.x","article-title":"Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis","volume":"81","author":"Famularo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2009.119321_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2249.1997.d01-991.x","article-title":"Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease","volume":"108","author":"Giacomelli","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2009.119321_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1136\/ard.2009.119321_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1136\/ard.2009.119321_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar2680","article-title":"The biological and clinical importance of the \u2018new generation\u2019 cytokines in rheumatic diseases","volume":"11","author":"Gabay","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.119321_bib12","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2009.119321_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.119321_bib14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2009.119321_bib15","article-title":"Interleukin-33 overexpression is associated with liver fibrosis in mice and humans","author":"Marvie","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1136\/ard.2009.119321_bib16","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.119321_bib17","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","article-title":"IL1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells","volume":"104","author":"Ali","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2009.119321_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1136\/ard.2009.119321_bib19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2009.119321_bib20","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2009.119321_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2018?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1136\/ard.2009.119321_bib22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"K\u00fcchler","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2009.119321_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2009.119321_bib24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.119321_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1136\/ard.2009.119321_bib26","series-title":"Organ involvement: Skin.","first-page":"389","author":"Clements","year":"1996"},{"key":"10.1136\/ard.2009.119321_bib27","article-title":"Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings","author":"Ibba-Manneschi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.119321_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000164720","article-title":"Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage","volume":"78","author":"Damjanov","year":"2009","journal-title":"Respiration"},{"key":"10.1136\/ard.2009.119321_bib29","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2009.119321_bib30","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2009.119321_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ Res"},{"key":"10.1136\/ard.2009.119321_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard.2009.119321_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"10.1136\/ard.2009.119321_bib34","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard.2009.119321_bib35","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1136\/ard.2009.119321_bib36","first-page":"S19","article-title":"Vascular involvement in systemic sclerosis (SSc)","volume":"22","author":"Kahaleh","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2009.119321_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-291X(02)02578-0","article-title":"ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation","volume":"299","author":"Oshikawa","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2009.119321_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01902140701198583","article-title":"ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis","volume":"33","author":"Tajima","year":"2007","journal-title":"Exp Lung Res"},{"key":"10.1136\/ard.2009.119321_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1189\/jlb.1006625","article-title":"Recombinant ST2 boosts hepatic Th2 response in vivo","volume":"82","author":"Amatucci","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.2009.119321_bib40","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.124.4.1206","article-title":"The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis","volume":"124","author":"Tajima","year":"2003","journal-title":"Chest"},{"key":"10.1136\/ard.2009.119321_bib41","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1006\/bbrc.2001.5090","article-title":"Identification of human ST2 protein in the sera of patients with autoimmune diseases","volume":"284","author":"Kuroiwa","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2009.119321_bib42","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"IL-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial NO production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1136\/ard.2009.119321_bib43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2009.119321_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.rdc.2007.12.006","article-title":"Vascular disease in scleroderma: angiogenesis and vascular repair","volume":"34","author":"Mulligan-Kehoe","year":"2008","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.119321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:13:59Z","timestamp":1737249239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724196057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0003496724196057"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.119321","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.119321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}